BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Chen C, Yang RX, Xu HG. STING and liver disease. J Gastroenterol 2021;56:704-12. [PMID: 34159442 DOI: 10.1007/s00535-021-01803-1] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
Number Citing Articles
1 Zhao Q, Bai J, Chen Y, Liu X, Zhao S, Ling G, Jia S, Zhai F, Xiang R. An optimized herbal combination for the treatment of liver fibrosis: Hub genes, bioactive ingredients, and molecular mechanisms. J Ethnopharmacol 2022;:115567. [PMID: 35870684 DOI: 10.1016/j.jep.2022.115567] [Reference Citation Analysis]
2 Wang HQ, Wan Z, Zhang Q, Su T, Yu D, Wang F, Zhang C, Li W, Xu D, Zhang H. Schisandrin B targets cannabinoid 2 receptor in Kupffer cell to ameliorate CCl4-induced liver fibrosis by suppressing NF-κB and p38 MAPK pathway. Phytomedicine 2022;98:153960. [PMID: 35121391 DOI: 10.1016/j.phymed.2022.153960] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
3 Wu JT, He BW, Cao JL, Yan JB, Chen ZY. Involvement of STING signaling pathway in non-alcoholic fatty liver disease. Shijie Huaren Xiaohua Zazhi 2021; 29(24): 1396-1401 [DOI: 10.11569/wcjd.v29.i24.1396] [Cited by in CrossRef: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]